SCHEMBL6233792

SCHEMBL6233792

Cc1ccccc1N(Cl)NC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.44
CTSL P07711 2/20 0.40
CTSB P07858 2/20 0.40
CTSS P25774 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
KDM4A O75164 1/20 0.37
MEN1 O00255 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
ATM Q13315 1/20 0.36
LCK P06239 2/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12060874 0.83 AKT1 (0.48) AKT1CTSLCTSBCTSSCA12
SCHEMBL28705848 0.80 AKT1 (0.50) AKT1CTSLCTSBCTSSCA12
SCHEMBL14108092 0.72 AKT1 (0.39) AKT1CTSLCTSBCTSSCA12
SCHEMBL12117478 0.71 LIPE (0.43)
SCHEMBL4514673 0.71 AKT1 (0.48) AKT1CTSLCTSBCTSSCA12
SCHEMBL5349941 0.70 LMNA (0.36) MEN1KMT2ATRPM8
SCHEMBL13636269 0.70 AKT1 (0.44) AKT1CTSLCTSBCTSSCA12
SCHEMBL1534089 0.69 NPC1 (0.58) NPC1RAB9AKMT2A
SCHEMBL9687622 0.69 AKT1 (0.38) AKT1CTSLCTSBCTSSCA12
SCHEMBL3124959 0.69 ALDH1A1 (0.55) KDM4AMEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
US-6214826-B1 NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 2001-04-10 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed